首页>
外国专利>
In situ hybridization of labeled oligonucleotide to antibody light chain sequence, useful for diagnosis of e.g. allergic, autoimmune and oncogenic diseases, in presence of formamide-free buffer
In situ hybridization of labeled oligonucleotide to antibody light chain sequence, useful for diagnosis of e.g. allergic, autoimmune and oncogenic diseases, in presence of formamide-free buffer
In the in situhybridization of at least one labeled oligonucleotide (ON) to detect a sequence (I) that encodes the light chain of an immunoglobulin, the new feature is that contact between the ON and (I) is in presence of a formamide-free buffer. Independent claims are also included for the following: (1) 3'-end labeling of ON, especially antisense sequences; (2) Formamide-free buffer solution (A) for the process; (3) ON probes, or probe mixtures, for detecting (I) comprising at least one of 10 specified sequences; and (4) Kit for the process comprising (A) and at least one probe of (3).
展开▼
机译: 结合人CD20的人单克隆抗体,该抗体能够在存在补体的情况下诱导表达CD2的细胞的补体依赖性细胞毒性,并且包含根据EP1558648B1的权利要求1的轻链和重链CDR区, i),(ii)(a)和(iii)(SEQ ID Nos.16、17、18、13、14和15),特别是包含轻链和重链可变区序列的抗体根据EP1558648B1的权利要求4(SEQ ID Nos.4和2),特别是ofatumumab